Private Vista’s CorMedix CRMD Stock Holding History

Private Vista’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$63K	Hold	10,000	–	–	0.03%	117
2020 Q1	$36K	Buy	+10,000	New	+$56.5K	0.01%	135

Other funds holding CRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Private Vista's CRMD Position: Q2 2020 in Review

Private Vista held its CorMedix (CRMD) position steady in Q2 2020 at 10,000 shares worth $63K. The position accounts for 0.03% of the portfolio, ranked #117.

Private Vista first reported a position in CRMD in Q1 2020 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold CRMD as of Q2 2020.

Private Vista held 10,000 shares of CorMedix worth $63K as of Q2 2020.
Private Vista left its CorMedix share count unchanged in Q2 2020.
CorMedix made up 0.03% of Private Vista's portfolio in Q2 2020, its #117 holding.
Private Vista first reported a position in CorMedix in Q1 2020 and has held it in 2 quarters since.
68 funds tracked by Wall St. Rank held CorMedix as of Q2 2020.

Based on Private Vista's 13F filing for Q2 2020, filed 31 Jul 2020.